Stepping down from inhaled corticosteroids with leukotriene inhibitors in asthma: A systematic review and meta-analysis

BACKGROUND: The risks of using leukotriene receptor antagonists (LTRA) as part of a strategy for stepping down inhaled corticosteroid (ICS) are not well known. OBJECTIVE: To estimate the risk of asthma exacerbation in individuals with stable asthma who start LTRA when stopping ICS or reducing ICS do...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Allergy Asthma Proc
Main Authors: Rank, Matthew A., Gionfriddo, Michael R., Pongdee, Thanai, Volcheck, Gerald W., Li, James T., Hagan, Christina R., Erwin, Patricia J., Hagan, John B.
Formato: Artigo
Idioma:Inglês
Publicado: OceanSide Publications, Inc. 2015
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405599/
https://ncbi.nlm.nih.gov/pubmed/25976437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2500/aap.2015.36.3839
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares